PITTSBURGH, Sept. 20 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) announced today that the regular quarterly cash dividend of $.06 per share will be payable on October 17, 2005, to shareholders of record at the close of business on September 30, 2005.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories, Inc., that develop, license, manufacture, market and distribute an extensive line of generic and proprietary products.

For more information about Mylan, visit www.mylan.com.

SOURCE Mylan Laboratories Inc.
09/20/2005
CONTACT: Public Relations, Patrick Fitzgerald, or Investor Relations,
Kris King, of Mylan Laboratories Inc., +1-724-514-1800


Web site: http://www.mylan.com
(MYL)